Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Assets Average (2016 - 2025)

Historic Assets Average for Catalyst Pharmaceuticals (CPRX) over the last 16 years, with Q3 2025 value amounting to $1.0 billion.

  • Catalyst Pharmaceuticals' Assets Average rose 3687.49% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 3687.49%. This contributed to the annual value of $660.8 million for FY2024, which is 5625.59% up from last year.
  • Latest data reveals that Catalyst Pharmaceuticals reported Assets Average of $1.0 billion as of Q3 2025, which was up 3687.49% from $940.4 million recorded in Q2 2025.
  • In the past 5 years, Catalyst Pharmaceuticals' Assets Average ranged from a high of $1.0 billion in Q3 2025 and a low of $194.8 million during Q1 2021
  • In the last 5 years, Catalyst Pharmaceuticals' Assets Average had a median value of $425.6 million in 2023 and averaged $489.7 million.
  • In the last 5 years, Catalyst Pharmaceuticals' Assets Average surged by 2443.46% in 2022 and then surged by 8378.52% in 2024.
  • Over the past 5 years, Catalyst Pharmaceuticals' Assets Average (Quarter) stood at $230.5 million in 2021, then soared by 53.73% to $354.4 million in 2022, then grew by 24.63% to $441.7 million in 2023, then soared by 83.79% to $811.7 million in 2024, then rose by 24.65% to $1.0 billion in 2025.
  • Its Assets Average stands at $1.0 billion for Q3 2025, versus $940.4 million for Q2 2025 and $880.1 million for Q1 2025.